Home Alzheimer’s Disease Phase II Trial of Leronlimab for COVID-19 Enrolls First Patients

Phase II Trial of Leronlimab for COVID-19 Enrolls First Patients

CytoDyn announced that it has enrolled and treated the first 2 patients with coronavirus disease 2019 (COVID-19) with leronlimab (PRO 140) – a treatment in the pipeline as a treatment for patients with triple-negative breast cancer (TNBC) – under its phase II randomized clinical trial, which is specifically for those with mild-to-moderate indications.1

The phase II clinical trial is a randomized, double-blind, placebo-controlled study evaluating the efficacy and safety of leronlimab and calls for 75 planned patients in up to 10 centers in the US.2

Additionally, leronlimab has now been administered to 15 severely ill patients with COVID-19 at 4 hospitals, with 10 patients being treated at a leading medical center in the New York City area and 5 patients at 3 other hospitals. The patients were all able to be administered the agent under an emergency investigational new drug (EIND),…

Continue Reading to the Source


Please enter your comment!
Please enter your name here

Most Popular

please help us fundraise (501c3 non-profit) : braincancer

I work with OurBrainBank, a start-up non-profit dedicated to moving glioblastoma from terminal to treatable, powered by patients.We're a registered 501c3 non-profit in the...

Cancer and Mental Health Re-post : braincancer

Hello!I would like to thank everyone who participated in my survey these past few months! I received a tremendous response and I truly, truly...

I put my feelings in music. : braincancer

Song LinkHi amigos. My 2year old son has been battling cancer for nearly 6 months and this song is just a expression of my...

Podcast Episode Interviewing Brain Cancer Fighter & Survivor : braincancer

Hi all, we have a podcast called Making Headway that is meant as a support for brain injury survivors. My co-host, Eryn, and I...

Recent Comments